Analyze the superb financial performance of Torrent Pharmaceuticals in the Q3 FY24 during which the company posted a whopping 52% rise in PAT to Rs 443 crores. Discover the functions that led to such success, the company’s broad initiatives, in terms of domestic and foreign markets.
![Torrent Pharma Q3 FY24 Results: PAT Hurries 52% to Rs 443 crore Torrent Pharma Q3 FY24 Results: PAT Hurries 52% to Rs 443 crore](https://www.promopenny.com/source/uploads/posts/posts170701767057236.jpg)